Literature DB >> 8655592

Nongenomic regulation of protein kinase C isoforms by the vitamin D metabolites 1 alpha,25-(OH)2D3 and 24R,25-(OH)2D3.

V L Sylvia1, Z Schwartz, E B Ellis, S H Helm, R Gomez, D D Dean, B D Boyan.   

Abstract

Prior studies have shown that vitamin D regulation of protein kinase C activity (PKC) in the cell layer of chondrocyte cultures is cell maturation-dependent. In the present study, we examined the membrane distribution of PKC and whether 1 alpha,25-(OH)2D3 and 24R,25-(OH)2D3 can directly regulate enzyme activity in isolated plasma membranes and extracellular matrix vesicles. Matrix vesicle PKC was activated by bryostatin-1 and inhibited by a PKC-specific pseudosubstrate inhibitor peptide. Depletion of membrane PKC activity using isoform-specific anti-PKC antibodies suggested that PKC alpha is the major isoform in cell layer lysates as well as in plasma membranes isolated from both cell types; PKC zeta is the predominant form in matrix vesicles. This was confirmed in Western blots of immunoprecipitates as well as in studies using control peptides to block binding of the isoform specific antibody to the enzyme and using a PKC zeta-specific pseudosubstrate inhibitor peptide. The presence of PKC zeta in matrix vesicles was further verified by immunoelectron microscopy. Enzyme activity in the matrix vesicle was insensitive to exogenous lipid, whereas that in the plasma membrane required lipid for full activity. 1,25-(OH)2D3 and 24,25-(OH)2D3 inhibited matrix vesicle PKC, but stimulated plasma membrane PKC when added directly to the isolated membrane fractions. PKC activity in the matrix vesicle was calcium-independent, whereas that in the plasma membrane required calcium. Moreover, the vitamin D-sensitive PKC in matrix vesicles was not dependent on calcium, whereas the vitamin D-sensitive enzyme in plasma membranes was calcium-dependent. It is concluded that PKC isoforms are differentially distributed between matrix vesicles and plasma membranes and that enzyme activity is regulated in a membrane-specific manner. This suggests the existence of a nongenomic mechanism whereby the effects of 1,25-(OH)2D3 and 24,25-(OH)2D3 may be mediated via PKC. Further, PKC zeta may be important in nongenomic, autocrine signal transduction at sites distal from the cell.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8655592     DOI: 10.1002/(SICI)1097-4652(199606)167:3<380::AID-JCP2>3.0.CO;2-L

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

1.  1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases.

Authors:  Barbara D Boyan; Kevin L Wong; Mimi Fang; Zvi Schwartz
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-16       Impact factor: 4.292

2.  Calcitriol mediates the activity of SGLT1 through an extranuclear initiated mechanism that involves intracellular signaling pathways.

Authors:  Carmen Castaneda-Sceppa; Francisco Castaneda
Journal:  J Physiol Biochem       Date:  2010-04-29       Impact factor: 4.158

3.  Selective enrichment of microRNAs in extracellular matrix vesicles produced by growth plate chondrocytes.

Authors:  Zhao Lin; Nicholas E Rodriguez; Junjun Zhao; Allison N Ramey; Sharon L Hyzy; Barbara D Boyan; Zvi Schwartz
Journal:  Bone       Date:  2016-04-12       Impact factor: 4.398

4.  Stathmin levels in growth plate chondrocytes are modulated by vitamin D3 metabolites and transforming growth factor-beta1 and are associated with proliferation.

Authors:  T W Hummert; Z Schwartz; V L Sylvia; D D Dean; B D Boyan
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

5.  The in vitro treatment with vitamin D3 is ineffective on the expression of PKC isoenzymes, but decreases further the impaired production of IL-2 in the T lymphocytes of SLE patients.

Authors:  Gabriella Czifra; Balázs Tóth; Ildikó Kovács; Tamás Bíró; Zoltán Griger; Sándor Baráth; Tünde Tarr; Margit Zeher; Sándor Sipka
Journal:  Rheumatol Int       Date:  2013-04-24       Impact factor: 2.631

6.  1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases.

Authors:  B D Boyan; Z Schwartz
Journal:  Cells Tissues Organs       Date:  2008-09-01       Impact factor: 2.481

Review 7.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

8.  Involvement of hydrogen peroxide in the differentiation of clonal HD-11EM cells into osteoclast-like cells.

Authors:  M J Steinbeck; J K Kim; M J Trudeau; P V Hauschka; M J Karnovsky
Journal:  J Cell Physiol       Date:  1998-09       Impact factor: 6.384

9.  Chaperone properties of pdia3 participate in rapid membrane actions of 1α,25-dihydroxyvitamin d3.

Authors:  Jiaxuan Chen; Kirill S Lobachev; Brian J Grindel; Mary C Farach-Carson; Sharon L Hyzy; Khairat B El-Baradie; Rene Olivares-Navarrete; Maryam Doroudi; Barbara D Boyan; Zvi Schwartz
Journal:  Mol Endocrinol       Date:  2013-05-09

10.  Treatment of resting zone chondrocytes with bone morphogenetic protein-2 induces maturation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3.

Authors:  Z Schwartz; V L Sylvia; Y Liu; D D Dean; B D Boyan
Journal:  Endocrine       Date:  1998-12       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.